Samrat Pharmachem Reports Q3 and Nine Months Ended December 31, 2025 Financial Results

Samrat Pharmachem Ltd. has reported its financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at INR 6,342.61 lakhs for the quarter and INR 21,794.80 lakhs for the nine months period. The total income for the quarter is INR 6,382.71 lakhs and INR 21,908.84 lakhs for the nine months period. The net profit for the quarter is INR (45.95) lakhs and INR 278.48 lakhs for the nine months period. The earnings per equity share for the quarter is INR (1.49) and INR 9.01 for the nine months period.